Over the past ten years, aortic valve replacement has become increasingly widespread for patients with severe aortic stenosis with the advancement of transcatheter aortic valve replacement (TAVR). While surgical aortic valve replacement (SAVR) was the historically available approach, TAVR eventually supplanted SAVR in number of procedures annually [ ] and is now available for patients in all surgical risk levels [ , ]. The TAVR procedure will continue to increase in its availability due to the ongoing improvement in the device and delivery system. Further, the prevalence of aortic stenosis is expected to continue to grow. Despite the disease being commonplace, racial disparities in aortic valve replacement remain an important issue and have been well-documented for SAVR and TAVR [ , ]. While they have been noted, it appears little progress has been made for some populations, specifically Asian Americans, who continue to be understudied and underrepresented.